Related Experiment Video
Updated: May 12, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
940
Integrating Bulk and Single-Cell Transcriptomic Data to Identify Ferroptosis-Associated Inflammatory Gene in
Huiqin Zhou1,2,3, Yunjia Peng2,3, Xinhua Huo2,3
1College of Life Sciences, Hunan Normal University, Changsha, People's Republic of China.
Journal of Inflammation Research
|February 17, 2025
Summary
This study identifies SLC11A1 as a key gene in Alzheimer's disease (AD), linking ferroptosis and neuroinflammation. Elevated SLC11A1 in microglia and monocytes suggests a novel pathway for AD development and potential therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Ferroptosis, an iron-dependent cell death, is implicated in various diseases but its role in Alzheimer's disease (AD) neuroinflammation and the brain-peripheral axis is unclear.
- Understanding the molecular links between ferroptosis, immune responses, and AD pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the cellular and molecular mechanisms connecting ferroptosis, immune inflammation, and the brain-peripheral blood axis in Alzheimer's disease.
- To identify novel candidate genes and pathways involved in AD pathogenesis using integrated multi-omics data.
Main Methods:
- Integrated bulk and single-cell RNA sequencing (RNA-seq) from AD brain and peripheral blood.
- Differential gene expression analysis, weighted gene co-expression network analysis (WGCNA), and cell-type-specific analysis.
- Validation of candidate genes in ferroptosis models using RT-qPCR and immunofluorescence.
Main Results:
- SLC11A1, an inflammatory gene, was identified as significantly upregulated in AD brain microglia and peripheral blood monocytes.
- A specific M1-type microglia subpopulation associated with ferroptosis expressed peripheral monocyte markers, suggesting a potential origin and role in neuroinflammation.
- Experimental validation confirmed SLC11A1 upregulation in ferroptosis-induced inflammatory microglia.
Conclusions:
- SLC11A1 plays a critical role in Alzheimer's disease, particularly in ferroptosis-mediated neuroinflammation.
- The study provides a novel molecular mechanistic insight into AD pathogenesis involving the brain-peripheral axis.
- Identified SLC11A1 as a potential therapeutic target for Alzheimer's disease.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

